| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |